Skip to content

In the BioHarmony Drug Report Database

Imipenem

Primaxin, Recarbrio (imipenem) is a small molecule pharmaceutical. Imipenem was first approved as Primaxin on 1985-11-26. It is used to treat bacterial endocarditis, bacterial infections, enterobacteriaceae infections, infectious bone diseases, and intraabdominal infections amongst others in the USA. It has been approved in Europe to treat gram-negative bacterial infections.
Trade Name Recarbrio
Common Name Imipenem
Indication bacterial endocarditis, bacterial infections, enterobacteriaceae infections, gram-negative bacterial infections, infectious bone diseases, intraabdominal infections, pelvic infection, pseudomonas infections, respiratory tract infections, staphylococcal infections, streptococcal infections, urinary tract infections
Drug Class Antibacterial antibiotics, carbapenem derivatives
Imipenem
Get full access now